WestEnd Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $656 | Hold |
3
| – | – | ﹤0.01% | 249 |
|
2025
Q1 | $672 | Buy |
3
+2
| +200% | +$448 | ﹤0.01% | 247 |
|
2024
Q4 | $328 | Hold |
1
| – | – | ﹤0.01% | 216 |
|
2024
Q3 | $300 | Hold |
1
| – | – | ﹤0.01% | 242 |
|
2024
Q2 | $329 | Hold |
1
| – | – | ﹤0.01% | 197 |
|
2024
Q1 | $396 | Hold |
1
| – | – | ﹤0.01% | 173 |
|
2023
Q4 | $352 | Hold |
1
| – | – | ﹤0.01% | 186 |
|
2023
Q3 | $375 | Buy |
+1
| New | +$375 | ﹤0.01% | 177 |
|
2023
Q2 | – | Hold |
0
| – | -$346 | – | 298 |
|
2023
Q1 | – | Sell |
-1
| Closed | -$235 | – | 182 |
|
2022
Q4 | $235 | Hold |
1
| – | – | ﹤0.01% | 212 |
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 337 |
|
2022
Q2 | $302 | Buy |
+1
| New | +$302 | ﹤0.01% | 172 |
|
2022
Q1 | – | Sell |
-1
| Closed | -$469 | – | 165 |
|
2021
Q4 | $469 | Buy |
+1
| New | +$469 | ﹤0.01% | 160 |
|
2021
Q3 | – | Hold |
0
| – | -$359K | – | 160 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 179 |
|